L2J

N-[(1R,2R,3S)-2-hydroxy-3-(10H-phenoxazin-10-yl)cyclohexyl]-4-(trifluoromethoxy)benzene-1-sulfonamide

Created:	2019-01-31
Last modified:	2020-05-06

Find Related PDB Entry
1 entries where L2J is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	59
Chiral Atom Count	3
Bond Count	63
Aromatic Bond Count	18

2D diagram of L2J

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	N-[(1R,2R,3S)-2-hydroxy-3-(10H-phenoxazin-10-yl)cyclohexyl]-4-(trifluoromethoxy)benzene-1-sulfonamide
Systematic Name (OpenEye OEToolkits)	~{N}-[(1~{R},2~{R},3~{S})-2-oxidanyl-3-phenoxazin-10-yl-cyclohexyl]-4-(trifluoromethyloxy)benzenesulfonamide
Formula	C₂₅ H₂₃ F₃ N₂ O₅ S
Molecular Weight	520.521
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	c3cc2N(c1ccccc1Oc2cc3)C4CCCC(C4O)NS(c5ccc(cc5)OC(F)(F)F)(=O)=O
SMILES	CACTVS	3.385	O[CH]1[CH](CCC[CH]1N2c3ccccc3Oc4ccccc24)N[S](=O)(=O)c5ccc(OC(F)(F)F)cc5
SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)N(c3ccccc3O2)C4CCCC(C4O)NS(=O)(=O)c5ccc(cc5)OC(F)(F)F
Canonical SMILES	CACTVS	3.385	O[C@H]1[C@@H](CCC[C@@H]1N2c3ccccc3Oc4ccccc24)N[S](=O)(=O)c5ccc(OC(F)(F)F)cc5
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1ccc2c(c1)N(c3ccccc3O2)[C@H]4CCC[C@H]([C@@H]4O)NS(=O)(=O)c5ccc(cc5)OC(F)(F)F
InChI	InChI	1.03	InChI=1S/C25H23F3N2O5S/c26-25(27,28)35-16-12-14-17(15-13-16)36(32,33)29-18-6-5-9-21(24(18)31)30-19-7-1-3-10-22(19)34-23-11-4-2-8-20(23)30/h1-4,7-8,10-15,18,21,24,29,31H,5-6,9H2/t18-,21+,24+/m1/s1
InChIKey	InChI	1.03	WGKGADVPRVLHHZ-ZHRMCQFGSA-N

Related Resource References

Resource Name	Reference
PubChem	91885558

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.